ResMed (RMD) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $220.37 -1.82%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $2.08, in-line with the analyst estimate of $2.08. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.22 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ResMed names Carol Burt as lead director as Ron Taylor retires
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Kaiser Aluminum names Fred Stephan as CEO, effective November 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
